Cargando…
Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome
Highly active antiretroviral therapy (HAART) has changed the face of human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS) by leading to dramatic decreases in HIV-related morbidity and mortality in the developed as well as developing world. Since the introduction of HAART, th...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636132/ https://www.ncbi.nlm.nih.gov/pubmed/18711267 |
_version_ | 1782164279178297344 |
---|---|
author | Venkatesh, Kartik K Biswas, J Kumarasamy, N |
author_facet | Venkatesh, Kartik K Biswas, J Kumarasamy, N |
author_sort | Venkatesh, Kartik K |
collection | PubMed |
description | Highly active antiretroviral therapy (HAART) has changed the face of human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS) by leading to dramatic decreases in HIV-related morbidity and mortality in the developed as well as developing world. Since the introduction of HAART, the incidence of ocular opportunistic infections causing retinitis has dramatically decreased, and clinicians should be aware of changes in the clinical presentation of ocular manifestations of HIV. As studies of HIV disease after the introduction of HAART continue to become available, more thorough descriptions of treated patients with ocular opportunistic infections will include side-effects and toxicities of therapy. This review focuses on the impact of HAART on the ocular manifestations of HIV. |
format | Text |
id | pubmed-2636132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-26361322009-02-10 Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome Venkatesh, Kartik K Biswas, J Kumarasamy, N Indian J Ophthalmol Symposium Highly active antiretroviral therapy (HAART) has changed the face of human immunodeficiency virus (HIV) acquired immune deficiency syndrome (AIDS) by leading to dramatic decreases in HIV-related morbidity and mortality in the developed as well as developing world. Since the introduction of HAART, the incidence of ocular opportunistic infections causing retinitis has dramatically decreased, and clinicians should be aware of changes in the clinical presentation of ocular manifestations of HIV. As studies of HIV disease after the introduction of HAART continue to become available, more thorough descriptions of treated patients with ocular opportunistic infections will include side-effects and toxicities of therapy. This review focuses on the impact of HAART on the ocular manifestations of HIV. Medknow Publications 2008 /pmc/articles/PMC2636132/ /pubmed/18711267 Text en Copyright: © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Symposium Venkatesh, Kartik K Biswas, J Kumarasamy, N Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome |
title | Impact of highly active antiretroviral therapy on ophthalmic manifestations in
human immunodeficiency virus / acquired immune deficiency syndrome |
title_full | Impact of highly active antiretroviral therapy on ophthalmic manifestations in
human immunodeficiency virus / acquired immune deficiency syndrome |
title_fullStr | Impact of highly active antiretroviral therapy on ophthalmic manifestations in
human immunodeficiency virus / acquired immune deficiency syndrome |
title_full_unstemmed | Impact of highly active antiretroviral therapy on ophthalmic manifestations in
human immunodeficiency virus / acquired immune deficiency syndrome |
title_short | Impact of highly active antiretroviral therapy on ophthalmic manifestations in
human immunodeficiency virus / acquired immune deficiency syndrome |
title_sort | impact of highly active antiretroviral therapy on ophthalmic manifestations in
human immunodeficiency virus / acquired immune deficiency syndrome |
topic | Symposium |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636132/ https://www.ncbi.nlm.nih.gov/pubmed/18711267 |
work_keys_str_mv | AT venkateshkartikk impactofhighlyactiveantiretroviraltherapyonophthalmicmanifestationsinhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome AT biswasj impactofhighlyactiveantiretroviraltherapyonophthalmicmanifestationsinhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome AT kumarasamyn impactofhighlyactiveantiretroviraltherapyonophthalmicmanifestationsinhumanimmunodeficiencyvirusacquiredimmunedeficiencysyndrome |